WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentPreface
View the documentIntroduction
Open this folder and view contentsParasitic infections
Open this folder and view contentsInsect and arachnid bites and stings
Open this folder and view contentsSuperficial fungal infections
Open this folder and view contentsSubcutaneous fungal infections
Open this folder and view contentsBacterial infections
Open this folder and view contentsViral infections
Open this folder and view contentsEczematous diseases
Open this folder and view contentsScaling diseases
Open this folder and view contentsPapulosquamous diseases
View the documentCutaneous reactions to drugs
Open this folder and view contentsPigmentary disorders
Open this folder and view contentsPremalignant lesions and malignant tumours
Open this folder and view contentsPhotodermatoses
Close this folderBullous dermatoses
View the documentPemphigus
View the documentBullous pemphigoid
View the documentDermatitis herpetiformis
View the documentAlopecia areata
View the documentUrticaria
Open this folder and view contentsConditions common in children
View the documentAcne vulgaris
View the documentPruritus
View the documentTropical ulcers
Open this folder and view contentsAntimicrobial drugs
Open this folder and view contentsAntifugal drugs
Open this folder and view contentsAntiseptic agents
Open this folder and view contentsKeratoplastic and keratolytic agents
Open this folder and view contentsScabicides and pediculicides
Open this folder and view contentsAnti-inflammatory and antipruritic drugs1
Open this folder and view contentsAntiallergics and drugs used in anaphylaxis
Open this folder and view contentsUltraviolet radiation-blocking agents (sunscreens)
Open this folder and view contentsMiscellaneous drugs
Open this folder and view contentsAnnex
View the documentSelected WHO Publications of Related Interest
View the documentBack cover
 

Bullous pemphigoid

Bullous pemphigoid, which occurs in elderly patients, is generally less severe than pemphigus. Spontaneous remission can occur and not all patients require systemic treatment. It is characterized by the formation of tense, often blood-filled, blisters in the skin, which tend to heal spontaneously. The blisters usually develop in the axillary and inguinal folds, but large areas of the body surface may be involved. However, in contrast to pemphigus vulgaris, their rupture does not result in large denuded areas of skin.

Treatment

Systemic corticosteroids are the mainstay of treatment, but they must be used at the lowest effective dosage. Treatment should be continued until the serum is clear of detectable antibody and then be withdrawn gradually. Dapsone is also effective. The dosage is the same as for dermatitis herpetiformis (see below).

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019